Fleury Approves Outpatient Oncology Venture With Atlântica

• Fleury’s board met on November 10, 2026, backing plans for a nationwide outpatient oncology platform through a special-purpose entity.
• Directors authorized a binding memorandum of understanding with Atlântica Hospitais e Participações, with ownership split 50.01% for Fleury and 49.99% for Atlântica.
• The majority owner will consolidate the entity’s financial results and oversee its medical, operational and commercial management.
• Its initial asset contribution will include new units already under development.
• Management was authorized to finalize transaction agreements, subject to customary closing conditions, including approval from competition regulator CADE.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fleury SA published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.